The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $90.47 million. The enterprise value is $74.13 million.
| Market Cap | 90.47M |
| Enterprise Value | 74.13M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 13.61 million shares outstanding. The number of shares has decreased by -6.65% in one year.
| Current Share Class | 13.61M |
| Shares Outstanding | 13.61M |
| Shares Change (YoY) | -6.65% |
| Shares Change (QoQ) | -1.51% |
| Owned by Insiders (%) | 16.48% |
| Owned by Institutions (%) | 34.06% |
| Float | 6.48M |
Valuation Ratios
The trailing PE ratio is 34.34 and the forward PE ratio is 10.90.
| PE Ratio | 34.34 |
| Forward PE | 10.90 |
| PS Ratio | 1.54 |
| Forward PS | 1.44 |
| PB Ratio | 7.44 |
| P/TBV Ratio | 7.39 |
| P/FCF Ratio | 39.95 |
| P/OCF Ratio | 25.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.32, with an EV/FCF ratio of 32.73.
| EV / Earnings | 26.23 |
| EV / Sales | 1.26 |
| EV / EBITDA | 17.32 |
| EV / EBIT | 27.33 |
| EV / FCF | 32.73 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.96 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.86 |
| Interest Coverage | 4.53 |
Financial Efficiency
Return on equity (ROE) is 18.55% and return on invested capital (ROIC) is 8.69%.
| Return on Equity (ROE) | 18.55% |
| Return on Assets (ROA) | 3.08% |
| Return on Invested Capital (ROIC) | 8.69% |
| Return on Capital Employed (ROCE) | 11.32% |
| Weighted Average Cost of Capital (WACC) | 11.03% |
| Revenue Per Employee | $177,942 |
| Profits Per Employee | $8,563 |
| Employee Count | 330 |
| Asset Turnover | 1.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $33,802 in taxes.
| Income Tax | 33,802 |
| Effective Tax Rate | 1.03% |
Stock Price Statistics
The stock price has decreased by -13.30% in the last 52 weeks. The beta is 1.16, so The Joint's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -13.30% |
| 50-Day Moving Average | 7.63 |
| 200-Day Moving Average | 8.50 |
| Relative Strength Index (RSI) | 35.88 |
| Average Volume (20 Days) | 71,900 |
Short Selling Information
The latest short interest is 349,244, so 2.57% of the outstanding shares have been sold short.
| Short Interest | 349,244 |
| Short Previous Month | 405,587 |
| Short % of Shares Out | 2.57% |
| Short % of Float | 5.39% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, The Joint had revenue of $58.72 million and earned $2.83 million in profits. Earnings per share was $0.19.
| Revenue | 58.72M |
| Gross Profit | 48.30M |
| Operating Income | 2.71M |
| Pretax Income | 3.28M |
| Net Income | 2.83M |
| EBITDA | 4.28M |
| EBIT | 2.71M |
| Earnings Per Share (EPS) | $0.19 |
Balance Sheet
The company has $18.30 million in cash and $1.95 million in debt, with a net cash position of $16.34 million or $1.20 per share.
| Cash & Cash Equivalents | 18.30M |
| Total Debt | 1.95M |
| Net Cash | 16.34M |
| Net Cash Per Share | $1.20 |
| Equity (Book Value) | 12.27M |
| Book Value Per Share | 0.89 |
| Working Capital | 16.12M |
Cash Flow
In the last 12 months, operating cash flow was $3.49 million and capital expenditures -$1.22 million, giving a free cash flow of $2.26 million.
| Operating Cash Flow | 3.49M |
| Capital Expenditures | -1.22M |
| Depreciation & Amortization | 1.57M |
| Net Borrowing | n/a |
| Free Cash Flow | 2.26M |
| FCF Per Share | $0.17 |
Margins
Gross margin is 82.25%, with operating and profit margins of 4.62% and 4.81%.
| Gross Margin | 82.25% |
| Operating Margin | 4.62% |
| Pretax Margin | 5.58% |
| Profit Margin | 4.81% |
| EBITDA Margin | 7.29% |
| EBIT Margin | 4.62% |
| FCF Margin | 3.86% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 6.65% |
| Shareholder Yield | 6.65% |
| Earnings Yield | 2.91% |
| FCF Yield | 2.50% |
Analyst Forecast
The average price target for The Joint is $9.00, which is 35.34% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.00 |
| Price Target Difference | 35.34% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.96% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |